FDA for the first time Just approved the device This allows people to browse cervical cancer from home.
Known as a turquoise wand, from Teal Health, the prescription device allows patients to collect samples and send them to the laboratory to receive the same tests that could possibly be carried out in the medical office.
In January, Teal Health announced a round of seeds of $ 10 million, which provides a total financing amount of as much as $ 23 million, at that point TechCrunch. Investors in the round were Serena Ventures, Chelsea Clinton, Emerson Collective and Forerunner. The device goals to make use of the indisputable fact that the test of cervical cancer, also often known as a slurry smear, will be quite intimidating for many people.
“The screening of cervical cancer is the most important and often the entry point for the woman’s health association,” said Kara Egan, co -founder and general director, said TechCrunch in January. “Over 1 in 4 women are currently delayed in the fact that life -saving shows.”
Cervical cancer was one of the most typical cancer for women, but more screening and prevention helped to cut back this, based on the American Cancer Society. The set of wands will contain a debt collection device and virtual access to medical service providers who review the results of the laboratory in the patient. The sets change into available in June, starting with California.